ID   YJBM_BACSU              Reviewed;         211 AA.
AC   O31611;
DT   19-JAN-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   07-APR-2021, entry version 100.
DE   RecName: Full=GTP pyrophosphokinase YjbM;
DE            EC=2.7.6.5 {ECO:0000269|PubMed:26460002};
DE   AltName: Full=(p)ppGpp synthase YjbM;
DE   AltName: Full=Small alarmone synthase 1 {ECO:0000303|PubMed:18067544};
DE            Short=SAS 1 {ECO:0000303|PubMed:18067544};
GN   Name=yjbM; OrderedLocusNames=BSU11600;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [2]
RP   FUNCTION AS A (P)PPGPP SYNTHASE, INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=168;
RX   PubMed=18067544; DOI=10.1111/j.1365-2958.2007.06018.x;
RA   Nanamiya H., Kasai K., Nozawa A., Yun C.S., Narisawa T., Murakami K.,
RA   Natori Y., Kawamura F., Tozawa Y.;
RT   "Identification and functional analysis of novel (p)ppGpp synthetase genes
RT   in Bacillus subtilis.";
RL   Mol. Microbiol. 67:291-304(2008).
RN   [3]
RP   INDUCTION.
RC   STRAIN=168;
RX   PubMed=22950019; DOI=10.1002/mbo3.16;
RA   Tagami K., Nanamiya H., Kazo Y., Maehashi M., Suzuki S., Namba E.,
RA   Hoshiya M., Hanai R., Tozawa Y., Morimoto T., Ogasawara N., Kageyama Y.,
RA   Ara K., Ozaki K., Yoshida M., Kuroiwa H., Kuroiwa T., Ohashi Y.,
RA   Kawamura F.;
RT   "Expression of a small (p)ppGpp synthetase, YwaC, in the (p)ppGpp(0) mutant
RT   of Bacillus subtilis triggers YvyD-dependent dimerization of ribosome.";
RL   MicrobiologyOpen 1:115-134(2012).
RN   [4] {ECO:0007744|PDB:5DEC, ECO:0007744|PDB:5DED, ECO:0007744|PDB:5F2V}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-211 APO-FORM AND IN COMPLEXES
RP   WITH ATP ANALOG OR PPPGPP, FUNCTION, REACTION MECHANISM, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, ACTIVE SITE, SUBUNIT, ATP-BINDING, AND
RP   MUTAGENESIS OF LYS-25; PHE-42; ARG-46; GLU-139 AND ASN-148.
RC   STRAIN=168 / PY79;
RX   PubMed=26460002; DOI=10.1073/pnas.1505271112;
RA   Steinchen W., Schuhmacher J.S., Altegoer F., Fage C.D., Srinivasan V.,
RA   Linne U., Marahiel M.A., Bange G.;
RT   "Catalytic mechanism and allosteric regulation of an oligomeric (p)ppGpp
RT   synthetase by an alarmone.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:13348-13353(2015).
CC   -!- FUNCTION: Functions as a (p)ppGpp synthase; GDP can be used instead of
CC       GTP, resulting in an increase of (p)ppGpp synthesis (PubMed:18067544).
CC       The enzyme binds ATP, then GDP or GTP and catalysis is highly
CC       cooperative (PubMed:26460002). In eubacteria ppGpp (guanosine 3'-
CC       diphosphate 5'-diphosphate) is a mediator of the stringent response
CC       that coordinates a variety of cellular activities in response to
CC       changes in nutritional abundance. Probably has a minor role in the
CC       stringent response (PubMed:18067544). {ECO:0000269|PubMed:18067544,
CC       ECO:0000269|PubMed:26460002}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + GTP = AMP + guanosine 3'-diphosphate 5'-triphosphate;
CC         Xref=Rhea:RHEA:22088, ChEBI:CHEBI:30616, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:142410, ChEBI:CHEBI:456215; EC=2.7.6.5;
CC         Evidence={ECO:0000269|PubMed:26460002};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22089;
CC         Evidence={ECO:0000305|PubMed:26460002};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + GDP = AMP + guanosine 3',5'-bis(diphosphate);
CC         Xref=Rhea:RHEA:28098, ChEBI:CHEBI:30616, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:77828, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:26460002};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28099;
CC         Evidence={ECO:0000305|PubMed:26460002};
CC   -!- ACTIVITY REGULATION: Allosterically regulated by its own products;
CC       pppGpp simulates synthesis 10-fold more than ppGpp. 2 pppGpp molecules
CC       bind in a regulatory cleft in the middle of the tetramer in an
CC       asymmetric manner. There is a specific contact of Lys-25 to the gamma-
CC       phosphate of pppGpp, explaining why pppGpp stimulates activity but
CC       ppGpp does not (PubMed:26460002). {ECO:0000269|PubMed:26460002}.
CC   -!- PATHWAY: Purine metabolism; ppGpp biosynthesis; ppGpp from GTP: step
CC       1/2.
CC   -!- SUBUNIT: Homotetramer (PubMed:26460002). {ECO:0000269|PubMed:26460002}.
CC   -!- INDUCTION: Expressed during exponential growth through the transition
CC       to the stationary phase, but not during entry of cells into stationary
CC       phase (PubMed:18067544). Protein continuously expressed with a peak at
CC       2 hours after inoculation, decreasing until 3.5 hours as cells enter
CC       stationary phase (at protein level) (PubMed:22950019).
CC       {ECO:0000269|PubMed:18067544, ECO:0000269|PubMed:22950019}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype, double yjbM-ywaC and triple
CC       relA-yjbM-ywaC mutants are also viable (PubMed:18067544).
CC       {ECO:0000269|PubMed:18067544}.
CC   -!- MISCELLANEOUS: The synthase activity of YjbM is greater than that of
CC       YwaC (PubMed:18067544). {ECO:0000269|PubMed:18067544}.
CC   -!- SIMILARITY: Belongs to the RelA/SpoT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL009126; CAB13017.1; -; Genomic_DNA.
DR   PIR; E69844; E69844.
DR   RefSeq; NP_389042.1; NC_000964.3.
DR   RefSeq; WP_003245294.1; NZ_JNCM01000035.1.
DR   PDB; 5DEC; X-ray; 2.00 A; A/B/C/D=2-211.
DR   PDB; 5DED; X-ray; 2.94 A; A/B/C/D/E/F/G/H=2-211.
DR   PDB; 5F2V; X-ray; 2.80 A; O/P/Q/R/S/T/U/V/W/X/Y/Z=3-211.
DR   PDBsum; 5DEC; -.
DR   PDBsum; 5DED; -.
DR   PDBsum; 5F2V; -.
DR   SMR; O31611; -.
DR   STRING; 224308.BSU11600; -.
DR   PaxDb; O31611; -.
DR   PRIDE; O31611; -.
DR   EnsemblBacteria; CAB13017; CAB13017; BSU_11600.
DR   GeneID; 939809; -.
DR   KEGG; bsu:BSU11600; -.
DR   PATRIC; fig|224308.179.peg.1249; -.
DR   eggNOG; COG2357; Bacteria.
DR   InParanoid; O31611; -.
DR   OMA; VWATIEH; -.
DR   PhylomeDB; O31611; -.
DR   BioCyc; BSUB:BSU11600-MONOMER; -.
DR   UniPathway; UPA00908; UER00884.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008728; F:GTP diphosphokinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015970; P:guanosine tetraphosphate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd05399; NT_Rel-Spo_like; 1.
DR   Gene3D; 3.30.460.10; -; 1.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR007685; RelA_SpoT.
DR   Pfam; PF04607; RelA_SpoT; 1.
DR   SMART; SM00954; RelA_SpoT; 1.
DR   SUPFAM; SSF81301; SSF81301; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; GTP-binding; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Reference proteome; Transferase.
FT   CHAIN           1..211
FT                   /note="GTP pyrophosphokinase YjbM"
FT                   /id="PRO_0000390876"
FT   NP_BIND         21..28
FT                   /note="pppGpp; allosteric activator; from two opposing
FT                   subunits"
FT                   /evidence="ECO:0000269|PubMed:26460002,
FT                   ECO:0007744|PDB:5DED"
FT   NP_BIND         41..42
FT                   /note="pppGpp; allosteric activator"
FT                   /evidence="ECO:0000269|PubMed:26460002,
FT                   ECO:0007744|PDB:5DED"
FT   NP_BIND         46..48
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:26460002,
FT                   ECO:0007744|PDB:5F2V"
FT   NP_BIND         56..59
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:26460002,
FT                   ECO:0007744|PDB:5F2V"
FT   ACT_SITE        139
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:26460002"
FT   METAL           72
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:26460002"
FT   BINDING         52
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:26460002,
FT                   ECO:0007744|PDB:5F2V"
FT   BINDING         72
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:26460002,
FT                   ECO:0007744|PDB:5F2V"
FT   BINDING         77
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:26460002,
FT                   ECO:0007744|PDB:5F2V"
FT   BINDING         148
FT                   /note="pppGpp; allosteric activator"
FT                   /evidence="ECO:0000269|PubMed:26460002,
FT                   ECO:0007744|PDB:5DED"
FT   MUTAGEN         25
FT                   /note="K->A: No stimulation of (p)ppGpp stimulation by
FT                   (p)ppGpp, protein still forms tetramers."
FT                   /evidence="ECO:0000269|PubMed:26460002"
FT   MUTAGEN         42
FT                   /note="F->A: No stimulation of (p)ppGpp stimulation by
FT                   (p)ppGpp, protein still forms tetramers."
FT                   /evidence="ECO:0000269|PubMed:26460002"
FT   MUTAGEN         46
FT                   /note="R->G: Loss of (p)ppGpp synthesis, protein still
FT                   forms tetramers."
FT                   /evidence="ECO:0000269|PubMed:26460002"
FT   MUTAGEN         139
FT                   /note="E->V: Loss of (p)ppGpp synthesis, protein still
FT                   forms tetramers."
FT                   /evidence="ECO:0000269|PubMed:26460002"
FT   MUTAGEN         148
FT                   /note="N->G: No stimulation of (p)ppGpp stimulation by
FT                   (p)ppGpp, protein still forms tetramers."
FT                   /evidence="ECO:0000269|PubMed:26460002"
FT   HELIX           4..31
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   STRAND          42..47
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   HELIX           50..59
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   HELIX           64..69
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   STRAND          73..82
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   HELIX           83..95
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   STRAND          97..107
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   HELIX           108..113
FT                   /evidence="ECO:0007744|PDB:5F2V"
FT   STRAND          119..129
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   STRAND          132..144
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   HELIX           145..160
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   TURN            161..163
FT                   /evidence="ECO:0007744|PDB:5DEC"
FT   HELIX           167..195
FT                   /evidence="ECO:0007744|PDB:5DEC"
SQ   SEQUENCE   211 AA;  24704 MW;  8FB2A73CE865FAA2 CRC64;
     MDDKQWERFL VPYRQAVEEL KVKLKGIRTL YEYEDDHSPI EFVTGRVKPV ASILEKARRK
     SIPLHEIETM QDIAGLRIMC QFVDDIQIVK EMLFARKDFT VVDQRDYIAE HKESGYRSYH
     LVVLYPLQTV SGEKHVLVEI QIRTLAMNFW ATIEHSLNYK YSGNIPEKVK LRLQRASEAA
     SRLDEEMSEI RGEVQEAQAA FSRKKKGSEQ Q
//
